I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …

The current document is based on a consensus reached by a panel of experts from the
Chinese Society of Allergy and the Chinese Society of Otorhinolaryngology-Head and Neck …

Background Chronic rhinosinusitis (CRS) has previously been thought to occur secondary to
infectious or obstructive etiologies. However, in recent years, primary CRS has been more …

Abstract The Korean Society of Otorhinolaryngology-Head and Neck Surgery and Korean
Rhinologic Society appointed a guideline development group (GDG) to establish a clinical …

Chronic rhinosinusitis (CRS) is an inflammatory condition of the paranasal sinuses defined
by classic symptoms, imaging findings, or endoscopic findings. There are a growing number …

Chronic rhinosinusitis (CRS) is a highly prevalent condition. CRS is usually managed with
intranasal corticosteroids, useful both before as well as after endoscopic sinus surgery …

Abstract Background Budesonide irrigations (BIs) are commonly used to control
inflammation in chronic rhinosinusitis (CRS). In 2016 we reported an analysis of long‐term …

Objective To analyze published reports on the efficacy and safety of CSI in CRS and
evaluate the clinical implications of current gaps in evidence. Corticosteroid irrigation (CSI) …

Objectives To address concerns related to the safety profile of both Food and Drug
Administration (FDA)–approved and non–FDA-approved intranasal corticosteroid (INCS) …

Background Budesonide high-volume saline irrigations (HVSIs) are routinely used to treat
chronic rhinosinusitis (CRS) due to improved sinonasal delivery and efficacy compared to …